FibroGen, Inc. (FGEN)

FibroGen Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	109	87	1,505	1,307	3,376	3,742
Market Cap Growth	-86.79%	-94.21%	15.15%	-61.27%	-9.80%	-4.85%
Enterprise Value	129	56	1,222	1,002	2,729	3,258
PE Ratio	-	-0.31	-5.13	-4.51	-17.83	-48.62
PS Ratio	0.62	0.59	10.70	5.56	19.15	14.59
PB Ratio	-1.02	-0.43	-70.18	6.25	8.00	7.25
P/FCF Ratio	-0.85	-0.27	-10.06	-14.95	43.50	-44.31
P/OCF Ratio	-0.85	-0.28	-10.31	-15.90	41.37	-47.55
EV/Sales Ratio	0.77	0.38	8.69	4.26	15.48	12.70
EV/EBITDA Ratio	-1.20	-0.21	-4.35	-3.66	-16.59	-62.29
EV/EBIT Ratio	-1.15	-0.21	-4.19	-3.47	-14.63	-44.17
EV/FCF Ratio	-0.93	-0.17	-8.17	-11.46	35.16	-38.58
Debt / Equity Ratio	-0.89	-1.00	-6.49	0.48	0.09	0.10
Debt / EBITDA Ratio	-0.94	-0.79	-0.49	-0.36	-0.24	-0.96
Debt / FCF Ratio	-0.74	-0.64	-0.93	-1.14	0.51	-0.59
Quick Ratio	1.09	1.14	1.60	1.87	4.46	5.47
Current Ratio	1.41	1.52	1.80	2.10	4.63	6.84
Asset Turnover	0.38	0.31	0.21	0.29	0.22	0.30
Interest Coverage	-12.25	-17.30	-202.68	-268.47	-77.66	-25.65
Return on Equity (ROE)	139.00%	213.50%	-440.40%	-99.40%	-43.80%	-13.80%
Return on Assets (ROA)	-54.50%	-58.70%	-44.30%	-36.00%	-23.10%	-8.90%
Return on Capital (ROIC)	912.44%	137470.73%	-255.60%	-93.42%	-41.54%	-15.78%
Earnings Yield	-230.22%	-326.11%	-19.51%	-22.19%	-5.61%	-2.06%
FCF Yield	-262.97%	-364.32%	-9.94%	-6.69%	2.30%	-2.26%
Buyback Yield / Dilution	-4.53%	-3.98%	-1.34%	-2.78%	-3.72%	-3.06%
Total Shareholder Return	-4.53%	-3.98%	-1.34%	-2.78%	-3.72%	-3.06%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).